You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 19, 2024

Details for Patent: 9,999,593

✉ Email this page to a colleague

« Back to Dashboard

Which drugs does patent 9,999,593 protect, and when does it expire?

Patent 9,999,593 protects ZIOPTAN and is included in one NDA.

This patent has eighty patent family members in twenty-six countries.

Summary for Patent: 9,999,593

Title:	Method and composition for treating ocular hypertension and glaucoma
Abstract:	The present invention relates to an ophthalmic aqueous composition containing PGF2.alpha. analogs for treating ocular hypertension and glaucoma, to a method for treating ocular hypertension and glaucoma by administering said composition to a subject in need of such treatment, and to a method for increasing aqueous solubility and stability of PGF2.alpha. analogs in an aqueous composition.
Inventor(s):	Reunamaki; Timo (Tampere, FI), Pellinen; Pertti (Lempaala, FI), Oksala; Olli (Tampere, FI), Lehmussaari; Kari (Tampere, FI)
Assignee:	SANTEN PHARMACEUTICAL CO., LTD. (Osaka-shi, Osaka, JP) ASAHI GLASS CO., LTD. (Chiyoda-Ku, Tokyo, JP)
Application Number:	12/995,351
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 9,999,593
Patent Claim Types: see list of patent claims	Formulation; Compound;

Drugs Protected by US Patent 9,999,593

Glossary

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Thea Pharma	ZIOPTAN	tafluprost	SOLUTION/DROPS;OPHTHALMIC	202514-001	Feb 10, 2012	AT	RX	Yes	Yes	⤷ Try a Trial	⤷ Try a Trial	Y				⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

Foreign Priority and PCT Information for Patent: 9,999,593

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
	08397513	May 30, 2008

PCT Information
PCT Filed	May 28, 2009	PCT Application Number:	PCT/JP2009/060211
PCT Publication Date:	December 03, 2009	PCT Publication Number:	WO2009/145356

International Family Members for US Patent 9,999,593

Subscribe to access the full database, or Try a Trial
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Argentina	071937	⤷ Try a Trial
Argentina	120961	⤷ Try a Trial
Australia	2009252210	⤷ Try a Trial
Brazil	PI0913109	⤷ Try a Trial
Canada	2724194	⤷ Try a Trial
Canada	2965185	⤷ Try a Trial
China	102083413	⤷ Try a Trial
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.